Serum matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 levels in patients with tick-borne encephalitis

Journal of Infection

Volumn 68, Issue 2, 2014, Pages 165-169

  Palus, Martin ^a,b   Žampachová, Eva ^c   Elsterová, Jana ^a,b   Růžek, Daniel ^a,d  

^a INSTITUTE OF PARASITOLOGY   (Czech Republic)

^b UNIVERSITY OF SOUTH BOHEMIA   (Czech Republic)

^c University of eské Budèjovice   (Czech Republic)

^d VETERINARY RESEARCH INSTITUTE   (Czech Republic)

Author keywords

Blood brain barrier; Matrix metalloproteinase 9; Tick borne encephalitis; Tissue inhibitor of metalloproteinase 1

Indexed keywords

GELATINASE B; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ADULT; AGED; ANALYTICAL PARAMETERS; ARTICLE; BLOOD ANALYSIS; BLOOD BRAIN BARRIER; CHILD; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME ANALYSIS; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MMP 9/TIMP 1 RATIO; NEUROPATHOLOGY; PROTEIN FUNCTION; SEX DIFFERENCE; TICK BORNE ENCEPHALITIS; UPREGULATION;

BLOOD-BRAIN BARRIER; MATRIX METALLOPROTEINASE-9; TICK-BORNE ENCEPHALITIS; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; ENCEPHALITIS, TICK-BORNE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; STATISTICS, NONPARAMETRIC; TISSUE INHIBITOR OF METALLOPROTEINASE-1; YOUNG ADULT;

EID: 84892440010     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2013.09.028     Document Type: Article

References (29)

1. Růžek D., Dobler G., Donoso Mantke O. Tick-borne encephalitis: pathogenesis and clinical implications. Travel Med Infect Dis 2010, 8(4):223-232.
2. Süss J. Increasing prevalence of early summer meningoencephalitis in Europe. Dtsch Med Wochenschr 2005, 130(22):1397-1400.
3. Süss J. Tick-borne encephalitis in Europe and beyond - the epidemiological situation as of 2007. Euro Surveill 2008, 13(26). pii: 18916.
4. Günther G., Haglund M. Tick-borne encephalopathies: epidemiology, diagnosis, treatment and prevention. CNS Drugs 2005, 19(12):1009-1032.
5. Růžek D., Salát J., Singh S.K., Kopecký J. Breakdown of the blood-brain barrier during tick-borne encephalitis in mice is not dependent on CD8+ T-cells. PLoS One 2011, 6(5):e20472.
6. Paul R., Lorenzl S., Koedel U., Sporer B., Vogel U., Frosch M., et al. Matrix metalloproteinases contribute to the blood-brain barrier disruption during bacterial meningitis. Ann Neurol 1998, 44(4):592-600.
7. Rosenberg G.A., Kornfeld M., Estrada E., Kelley R.O., Liotta L.A., Stetler-Stevenson W.G. TIMP-2 reduces proteolytic opening of blood-brain barrier by type IV collagenase. Brain Res 1992, 576(2):203-207.
8. Roe K., Kumar M., Lum S., Orillo B., Nerurkar V.R., Verma S. West Nile virus-induced disruption of the blood-brain barrier in mice is characterized by the degradation of the junctional complex proteins and increase in multiple matrix metalloproteinases. J Gen Virol 2012, 93(Pt 6):1193-1203.
9. Ichiyama T., Siba P., Suarkia D., Takasu T., Miki K., Kira R., et al. Serum levels of matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases 1 in subacute sclerosing panencephalitis. J Neurol Sci 2007, 252(1):45-48.
10. Ichiyama T., Matsushige T., Siba P., Suarkia D., Takasu T., Miki K., et al. Cerebrospinal fluid levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in subacute sclerosing panencephalitis. J Infect 2008, 56(5):376-380.
11. Lacraz S., Nicod L.P., Chicheportiche R., Welgus H.G., Dayer J.M. IL-10 inhibits metalloproteinase and stimulates TIMP-1 production in human mononuclear phagocytes. J Clin Invest 1995, 96(5):2304-2310.
12. Matsuura E., Umehara F., Hashiguchi T., Fujimoto N., Okada Y., Osame M. Marked increase of matrix metalloproteinase 9 in cerebrospinal fluid of patients with fungal or tuberculous meningoencephalitis. J Neurol Sci 2000, 173(1):45-52.
13. Liuzzi G.M., Mastroianni C.M., Santacroce M.P., Fanelli M., D'Agostino C., Vullo V., et al. Increased activity of matrix metalloproteinases in the cerebrospinal fluid of patients with HIV-associated neurological diseases. J Neurovirol 2000, 6(2):156-163.
14. Martínez-Torres F.J., Wagner S., Haas J., Kehm R., Sellner J., Hacke W., et al. Increased presence of matrix metalloproteinases 2 and 9 in short- and long-term experimental herpes simplex virus encephalitis. Neurosci Lett 2004, 368(3):274-278.
15. Ichiyama T., Morishima T., Kajimoto M., Matsushige T., Matsubara T., Furukawa S. Matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases 1 in influenza-associated encephalopathy. Pediatr Infect Dis J 2007, 26(6):542-544.
16. Tigabu B., de Kok-Mercado F., Holbrook M.R. Neuroviral infections and immunity. Neuroviral infections: general principles and DNA viruses 2013, 21-61. CRC Press. S.K. Singh, D. Růžek (Eds.).
17. Chekhonin V.P., Zhirkov Y.A., Belyaeva I.A., Ryabukhin I.A., Gurina O.I., Dmitriyeva T.B. Serum time course of two brain-specific proteins, alpha(1) brain globulin and neuron-specific enolase, in tick-born encephalitis and Lyme disease. Clin Chim Acta 2002, 320(1-2):117-125.
18. Moniuszko A., Pancewicz S., Czupryna P., Grygorczuk S., Świerzbińska R., Kondrusik M., et al. ssICAM-1, IL-21 and IL-23 in patients with tick borne encephalitis and neuroborreliosis. Cytokine 2012, 60(2):468-472.
19. Rosenberg G.A. Matrix metalloproteinases and their multiple roles in neurodegenerative diseases. Lancet Neurol 2009, 8(2):205-216.
20. Gasche Y., Copin J.C., Sugawara T., Fujimura M., Chan P.H. Matrix metalloproteinase inhibition prevents oxidative stress-associated blood-brain barrier disruption after transient focal cerebral ischemia. J Cereb Blood Flow Metab 2001, 21(12):1393-1400.
21. Kolev K., Skopál J., Simon L., Csonka E., Machovich R., Nagy Z. Matrix metalloproteinase-9 expression in post-hypoxic human brain capillary endothelial cells: H2O2 as a trigger and NF-kappaB as a signal transducer. Thromb Haemost 2003, 90(3):528-537.
22. Hsieh H.L., Wu C.Y., Yang C.M. Bradykinin induces matrix metalloproteinase-9 expression and cell migration through a PKC-delta-dependent ERK/Elk-1 pathway in astrocytes. Glia 2008, 56(6):619-632.
23. Dunyewicz M., Mertenová J., Moravcová E., Kulková H. Corticoids in the therapy of TBE and other viral encephalitides. Tick-borne encephalitis 1981, 36-44. Facultas-Verlag. C. Kunz (Ed.).
24. Rosenberg G.A., Dencoff J.E., Correa N., Reiners M., Ford C.C. Effect of steroids on CSF matrix metalloproteinases in multiple sclerosis: relation to blood-brain barrier injury. Neurology 1996, 46(6):1626-1632.
25. Wang P., Dai J., Bai F., Kong K.F., Wong S.J., Montgomery R.R., et al. Matrix metalloproteinase 9 facilitates West Nile virus entry into the brain. J Virol 2008, 82(18):8978-8985.
26. Haglund M., Forsgren M., Lindh G., Lindquist L. A 10-year follow-up study of tick-borne encephalitis in the Stockholm area and a review of the literature: need for a vaccination strategy. Scand J Infect Dis 1996, 28(3):217-224.
27. Toporkova M.G., Aleshin S.E., Ozherelkov S.V., Nadezhdina M.V., Stephenson J.R., Timofeev A.V. Serum levels of interleukin 6 in recently hospitalized tick-borne encephalitis patients correlate with age, but not with disease outcome. Clin Exp Immunol 2008, 152(3):517-521.
28. Atrasheuskaya A.V., Fredeking T.M., Ignatyev G.M. Changes in immune parameters and their correction in human cases of tick-borne encephalitis. Clin Exp Immunol 2003, 131(1):148-154.
29. Kříž B., Beneš C., Danielová V., Daniel M. Socio-economic conditions and other anthropogenic factors influencing tick-borne encephalitis incidence in the Czech Republic. Int J Med Microbiol 2004, 293(Suppl. 37):63-68.